Compare AANJANEYA LIFECARE with Orchid Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ORCHID PHARMA - Comparison Results

ORCHID PHARMA 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ORCHID PHARMA DR. DATSONS LABS/
ORCHID PHARMA
 
P/E (TTM) x -10.9 -163.5 - View Chart
P/BV x 0.2 46.9 0.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ORCHID PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ORCHID PHARMA
Sep-13
DR. DATSONS LABS/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs126194 64.7%   
Low Rs3135 88.3%   
Sales per share (Unadj.) Rs133.0276.5 48.1%  
Earnings per share (Unadj.) Rs0.2-79.2 -0.2%  
Cash flow per share (Unadj.) Rs6.6-43.5 -15.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.853.9 238.8%  
Shares outstanding (eoy) m31.6670.45 44.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.60.4 142.1%   
Avg P/E ratio x516.1-1.4 -35,704.7%  
P/CF ratio (eoy) x11.8-2.6 -449.4%  
Price / Book Value ratio x0.62.1 28.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4778,067 30.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m562,527 2.2%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m4,21119,477 21.6%  
Other income Rs m79407 19.3%   
Total revenues Rs m4,28919,884 21.6%   
Gross profit Rs m5691,103 51.6%  
Depreciation Rs m2042,519 8.1%   
Interest Rs m4305,227 8.2%   
Profit before tax Rs m13-6,236 -0.2%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m5-5,580 -0.1%  
Gross profit margin %13.55.7 238.5%  
Effective tax rate %48.02.0 2,392.4%   
Net profit margin %0.1-28.7 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85211,014 62.2%   
Current liabilities Rs m6,71132,060 20.9%   
Net working cap to sales %3.3-108.1 -3.1%  
Current ratio x1.00.3 297.2%  
Inventory Days Days16195 169.5%  
Debtors Days Days31834 949.1%  
Net fixed assets Rs m3,67329,440 12.5%   
Share capital Rs m317705 44.9%   
"Free" reserves Rs m3,7612,043 184.1%   
Net worth Rs m4,0783,800 107.3%   
Long term debt Rs m1,6719,018 18.5%   
Total assets Rs m12,63346,510 27.2%  
Interest coverage x1.0-0.2 -533.1%   
Debt to equity ratio x0.42.4 17.3%  
Sales to assets ratio x0.30.4 79.6%   
Return on assets %3.4-0.8 -453.1%  
Return on equity %0.1-146.9 -0.1%  
Return on capital %7.7-3.7 -205.5%  
Exports to sales %22.937.9 60.4%   
Imports to sales %14.322.6 63.2%   
Exports (fob) Rs m9647,378 13.1%   
Imports (cif) Rs m6024,406 13.7%   
Fx inflow Rs m9647,513 12.8%   
Fx outflow Rs m6075,649 10.7%   
Net fx Rs m3571,865 19.1%   
CASH FLOW
From Operations Rs m1,3451,682 80.0%  
From Investments Rs m-2,256-9,860 22.9%  
From Financial Activity Rs m-1,2006,644 -18.1%  
Net Cashflow Rs m-2,111-1,535 137.5%  

Share Holding

Indian Promoters % 4.5 32.3 14.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 1.4 3.3 40.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 94.1 55.3 170.2%  
Shareholders   20,807 84,811 24.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   NATCO PHARMA  PFIZER  ALEMBIC PHARMA  SHASUN PHARMA  SANOFI INDIA  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 154 Points Lower, Nifty Ends at 14,834; Bajaj Finance and UPL Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

A Critical Update on the Market(Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis(Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy(Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers(Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 5-YR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS